Author:
Tang Xiaolong,Yan Zaihua,Miao Yandong,Ha Wuhua,Li Zheng,Yang Lixia,Mi Denghai
Abstract
As an essential nutrient, copper’s redox properties are both beneficial and toxic to cells. Therefore, leveraging the characteristics of copper-dependent diseases or using copper toxicity to treat copper-sensitive diseases may offer new strategies for specific disease treatments. In particular, copper concentration is typically higher in cancer cells, making copper a critical limiting nutrient for cancer cell growth and proliferation. Hence, intervening in copper metabolism specific to cancer cells may become a potential tumor treatment strategy, directly impacting tumor growth and metastasis. In this review, we discuss the metabolism of copper in the body and summarize research progress on the role of copper in promoting tumor cell growth or inducing programmed cell death in tumor cells. Additionally, we elucidate the role of copper-related drugs in cancer treatment, intending to provide new perspectives for cancer treatment.
Reference216 articles.
1. Dietary reference intakes: vitamin a, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc;Trumbo;J Am Diet Assoc,2001
2. Copper biology;Tsang;Curr Biol,2021
3. Iron and copper metabolism;Arredondo;Mol Aspects Med,2005
4. Effects of metal chelating agents on the oxidation of lipids induced by copper and iron;Yoshida;Biochim Biophys Acta,1993
5. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1;Juarez;Clin Cancer Res,2006
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献